Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Carboplatin, and Etoposide vs 5-Fluorouracil and Folinic Acid in Adenocarcinoma of Unknown Primary
NCT00003558Phase 3Unknown
- Sponsor
- Maastricht University Medical Center+
- Start
- Aug 1998
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Adenocarcinoma comparing Paclitaxel + Carboplatin + Etoposide with Fluorouracil + Leucovorin Calcium (2 arms). Primary endpoint: Overall Survival up to 1 year. Status: unknown.
02
Drugs
paclitaxelcarboplatinetoposidefluorouracilfolinic acid
03
Conditions
Adenocarcinoma
Beyond the preview
Go deeper on NCT00003558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003558.